| 产品详情 |
| Edit |   |
|---|
| Product Name | Elacridar |
|---|
| Description | Purity >98%. Elacridar is a dual inhibitor of P-glycoprotein (MRP-1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2). It maximally inhibits P-glycoprotein in isolated human peripheral blood leukocytes at 200 nM. Elacridar blocks the activity of P-glycoprotein at the blood-brain barrier, altering the pharmacokinetics of certain drugs in the brain. This compound is effective against both human BCRP and the mouse homolog, Bcrp1. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide, GF120918, GW0918, GG918 |
|---|
| Gene, Accession, CAS # | CAS: 143664-11-3 |
|---|
| Catalog # | LS-H7641 |
|---|
| Price | |
|---|
| Order / More Info | Elacridar from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|